会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 51. 发明授权
    • Sheet processing apparatus and sheet processing method
    • 片材处理设备和片材处理方法
    • US07434804B2
    • 2008-10-14
    • US10794517
    • 2004-03-05
    • Takako HanadaHiromichi TsujinoYuzo MatsumotoMitsushige Murata
    • Takako HanadaHiromichi TsujinoYuzo MatsumotoMitsushige Murata
    • B65H5/34
    • B65H5/06
    • A sheet processing apparatus which is capable of discharging a sheet at the optimum sheet discharging speed without stopping the conveyance of the sheet irrespective of differences in sheet conveying speed according to sheet types. A sheet discharging motor is controlled to drive a discharging roller to convey sheets in selected one of a first state in which the sheets are conveyed at speeds within a first speed range specified by a first maximum speed and a first minimum speed, and a second state in which the sheets are conveyed at speeds within a second speed range specified by a second maximum speed lower than the first maximum speed and a second minimum speed lower than the first minimum speed. The first speed range includes an overlapping range where the first speed range and the second speed range overlap.
    • 一种纸张处理设备,其能够以不同的纸张类型的纸张输送速度的差异而不停止纸张的输送而以最佳纸张排出速度排出纸张。 控制片材排出马达以驱动排出辊以在第一状态中选定的一个状态下输送纸张,其中纸张以由第一最大速度和第一最小速度指定的第一速度范围内的速度传送,并且第二状态 其中纸张以低于第一最大速度的第二最大速度和低于第一最小速度的第二最小速度指定的第二速度范围内的速度传送。 第一速度范围包括第一速度范围和第二速度范围重叠的重叠范围。
    • 59. 发明授权
    • Dihydropyridine compounds and pharmaceutical compositions containing them
    • 二氢吡啶化合物和含有它们的药物组合物
    • US4727082A
    • 1988-02-23
    • US908350
    • 1986-09-17
    • Takashi FujikuraNoriki ItoYuzo MatsumotoYasuo IsomuraMasaharu AsanoToichi Takenaka
    • Takashi FujikuraNoriki ItoYuzo MatsumotoYasuo IsomuraMasaharu AsanoToichi Takenaka
    • C07D211/82A61K31/44A61K31/455A61P9/00A61P9/06A61P9/08A61P9/10A61P9/12A61P25/02A61P25/28C07D211/90C07D401/12
    • C07D401/12C07C317/00C07C323/00C07D211/90
    • A dihydropyridine compound of the following general formula (I) or a salt thereof: ##STR1## wherein R.sup.1 and R.sup.2, which are the same or different, each represents a C.sub.1 to C.sub.10 alkyl group, a lower alkyl group which is interrupted by oxygen atom(s), or a lower alkyl group substituted by C.sub.3 to C.sub.6 alicyclic group(s); R.sup.3 and R.sup.4, which are the same or different, each represents a lower alkyl group; R.sup.5 and R.sup.6, which are the same or different, each represents a hydrogen atom, a nitro group, a halogen atom, a lower alkyl group, a lower alkoxy group, a lower alkylthio group, a lower alkylsulfonyl group, or a lower alkylsulfinyl group; R.sup.7 and R.sup.8, which are the same or different, each represents a hydrogen atom, a halogen atom, a cyano group, a lower alkoxy group, or a lower alkanoylamino group, or R.sup.7 may combine with R.sup.8 to form a naphthyl group together with the adjacent phenyl group; A represents a single bond, a vinylene group (--CH.dbd.CH--), or a ethynylene group (--C.dbd.C--); B represents a single bond or --CH.sub. 2 O--; and m and n, which are the same or different, each represents 0 or an integer of 1 to 5.The compounds are useful for the treatment of various cardiovascular disorders, since they possess both Ca.sup.2+ -antagonistic and adrenergic beta-receptor blocking activities.
    • 下列通式(I)的二氢吡啶化合物或其盐:其中R 1和R 2相同或不同,各自表示C1至C10烷基,低级烷基 其被氧原子或被C3-C6脂环族基团取代的低级烷基取代; R 3和R 4相同或不同,各自表示低级烷基; R 5和R 6相同或不同,分别表示氢原子,硝基,卤素原子,低级烷基,低级烷氧基,低级烷硫基,低级烷基磺酰基或低级烷基亚磺酰基 ; R 7和R 8相同或不同,各自表示氢原子,卤素原子,氰基,低级烷氧基或低级烷酰氨基,或者可以与R 8结合形成萘基, 相邻苯基; A表示单键,亚乙烯基(-CH = CH-)或亚乙炔基(-C = C-); B表示单键或-CH 2 O-; 和m和n相同或不同,各自表示0或1至5的整数。该化合物可用于治疗各种心血管疾病,因为它们具有Ca 2+拮抗剂和肾上腺素能β受体阻断活性。